News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

More Transparency for Provider Prices and Quality Is Goal of Employers and Private Payers During 2013

Clinical laboratories and pathology groups will soon find it important to make it easier for patients to price for medical laboratory tests

Value-based reimbursement is the new frontier for the American healthcare system. Surveys show that employers and insurers are actively pushing the healthcare marketplace to a value-based, competitive paradigm. This means providers—including pathology groups and clinical laboratories—will be asked to deliver greater transparency in both the price and quality of their clinical services. (more…)

Clinical Pathology Laboratories Ignore the Rapid Growth of Mobile Apps in Healthcare at Their Peril

Pathology groups and clinical laboratories have opportunity to use mHealth to add value to clinicians

Experts predict that healthcare’s use of mobile apps—now being described as mHealth—will evolve into a distinct and primary information channel that will play a significant role in clinical care. This includes how anatomic and clinical pathologists use laboratory medicine to support clinical care.

“[M]obile is a technology that winds its way through everything we’re doing and we’re planning to do,” declared Bryan Sivak, Chief Technology Officer at the U.S. Department of Health & Human Services (HHS), in a recent story published in Modern Healthcare (MH).”[It is] a channel to deliver content… a great way for us to collect more real-time information and connect physicians and patients with each other.” (more…)

Growth of Medicare and Private Payer ACOs Shows Acceptance of New Care Model

Pathologists and clinical laboratory administrators have an opportunity to add value to physicians who are transitioning to new ACO model

It is good news for advocates of accountable care organizations (ACOs). Since the beginning of 2012, an ever-growing number of provider organizations have signed up to participate in Medicare ACO contracts.

This steady increase in the number of hospitals and health systems participating in Medicare and private payer ACOs will have at one interesting consequence. It means that the clinical laboratories will be part of the clinical service mix for the ACOs operated by the hospitals and health systems. (more…)

Big Healthcare Acquisitions Make News, Change Competitive Landscape for Clinical Pathology Laboratories

Pathologists and clinical laboratory managers should not be surprised to see today’s nontraditional healthcare delivery models becoming tomorrow’s industry norm

Big healthcare players are spending hundreds of millions of dollars to acquire unexpected targets. The biggest of these deals signal that healthcare consolidation and integration is a continuing trend. It is also a reminder to clinical laboratory managers and pathologists that the competitive healthcare marketplace is transforming at a steady pace.

Three such deals emphasize that the consolidation trend is alive and well:

  • Dignity Health purchased U.S. Healthworks this summer. No terms were disclosed, but some analysts estimate that the purchase price may have been more than $500 million.
  • DaVita Partners, a major player in dialysis services, is to purchase Healthcare Partners for $4.4 billion. Healthcare Partners operates 150 clinics in three states, plus has a national network of 8,300 independent physicians.
  • United HealthGroup, Inc., in deal announced last fall, acquired Monarch Healthcare, an independent physician association with 2,300 doctors in Southern California. Purchase price was not announced.

Acquisitions Have Potential to Reshape Competitive Landscape (more…)

FDA Issues Proposed Rule on Medical Device UDI System That Will Also Apply to Clinical Pathology Analyzers and Lab Products

Many products that medical laboratories use will be covered under the new UDI system

You’re reading it here first! UPCs—universal product codes—are coming soon to the medical laboratory analyzers and other products that your clinical laboratory purchases. Under a proposed rule published by the Food and Drug Administration (FDA), medical devices will soon have UDIs—universal device identifiers.

You know about UPCs. Those are the ubiquitous “universal product codes” that are found on literally every retail product. UPCs make scanning at the cash register possible. Now a similar system is coming to medical devices, including the lab analyzers, reagents, and other products used by medical laboratories and pathology. (more…)

;